Philadelphia Business Journal Honors David Wallace for Technology Creativity and Ingenuity
King of Prussia, PA – March 23, 2016 – Greenphire, the industry leader in global clinical trial payment solutions, announced today that its Chief Technology Officer,David Wallace, has been honored with a 2016 Tech Disruptor Award for his commitment to bringing innovative technology to the growing Philadelphia technology scene.
“I am honored to be recognized among a group of such elite technology leaders in the Philadelphia area,” said David Wallace, CTO of Greenphire. “This award validates the collaboration and dedication that our team has in building innovative technology solutions to optimize clinical trial operations and improve the study experience for all stakeholders.”
As Chief Technology Officer, David leads the development of Greenphire’s technology solutions that automate payments for the clinical trial industry, while ensuring the infrastructure is secure, scalable and reliable. Leveraging a proven agile methodology, David and his team continuously work to refine and further develop Greenphire’s solutions to support client needs and take the technology to the next level. Additionally, David works closely with Greenphire’s product team to ensure the Company’s innovative solutions are designed to address the needs of clinical trials today and well into the future.
With more than twenty years of experience, David has an extremely valuable combination of technology strategy, architecture design, integration, and product development experience in rapidly growing SaaS-based businesses.
David will be honored on April 14, 2016 at the 2016 Tech Disruptor Awards at the Sheraton Philadelphia Downtown Hotel.
About Greenphire
Greenphire is the leader in global clinical trial payment solutions. Greenphire’s best-in-class solutions optimize clinical trial performance by simplifying and streamlining payment processes from sponsors and CROs to sites and patients. Greenphire’s ClinCard and eClinicalGPS solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials.
